ArticleThe Journal of infectious diseases2024

Recombinant Full-length Plasmodium falciparum Circumsporozoite Protein-Based Vaccine Adjuvanted With Glucopyranosyl Lipid A-Liposome Quillaja saponaria 21: Results of Phase 1 Testing With Malaria Challenge.

DeAnna J Friedman-Klabanoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.